These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17882892)

  • 1. QRISK--a new CVD risk score.
    Savill P
    Practitioner; 2007 Aug; 251(1697):7. PubMed ID: 17882892
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular risk can be represented by scaled rectangle diagrams.
    Marshall RJ
    J Clin Epidemiol; 2009 Sep; 62(9):998-1000. PubMed ID: 19635404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the SCORE and Wilson-Grundy methods for the assessment of cardiovascular risk in community pharmacies.
    Amariles P; Machuca M; Faus MJ; Baena MI; Martinez-Martinez F; Jimenez-Martin J
    J Clin Pharm Ther; 2008 Oct; 33(5):475-81. PubMed ID: 18834361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease knowledge and risk perception among underserved individuals at increased risk of cardiovascular disease.
    Homko CJ; Santamore WP; Zamora L; Shirk G; Gaughan J; Cross R; Kashem A; Petersen S; Bove AA
    J Cardiovasc Nurs; 2008; 23(4):332-7. PubMed ID: 18596496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
    Cooney MT; Dudina AL; Graham IM
    J Am Coll Cardiol; 2009 Sep; 54(14):1209-27. PubMed ID: 19778661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
    Wells S; Furness S; Rafter N; Horn E; Whittaker R; Stewart A; Moodabe K; Roseman P; Selak V; Bramley D; Jackson R
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):173-8. PubMed ID: 18391644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CVD risk assessment: do we need the metabolic syndrome or better global cardiometabolic risk calculators?
    Després JP
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S1-4. PubMed ID: 18469833
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular Risk and Risk Scores: ASSIGN, Framingham, QRISK and others: how to choose.
    Tunstall-Pedoe H
    Heart; 2011 Mar; 97(6):442-4. PubMed ID: 21339319
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
    Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A
    N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Model for estimation of cardiovascular risk in Norway].
    Selmer R; Lindman AS; Tverdal A; Pedersen JI; Njølstad I; Veierød MB
    Tidsskr Nor Laegeforen; 2008 Jan; 128(3):286-90. PubMed ID: 18264151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus.
    O'Neill SG; Pego-Reigosa JM; Hingorani AD; Bessant R; Isenberg DA; Rahman A
    Rheumatology (Oxford); 2009 May; 48(5):573-5. PubMed ID: 19273540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge and risk of cardiovascular disease in rural Alabama women.
    Hamner J; Wilder B
    J Am Acad Nurse Pract; 2008 Jun; 20(6):333-8. PubMed ID: 18588661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of dietary evaluation in cardiovascular disease risk prediction models increases accuracy and reduces bias of the estimations.
    Panagiotakos DB; Pitsavos C; Stefanadis C
    Risk Anal; 2009 Feb; 29(2):176-86. PubMed ID: 19000082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany.
    Hense HW; Koesters E; Wellmann J; Meisinger C; Völzke H; Keil U
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):409-15. PubMed ID: 18677164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
    Colvine K; Kerr AJ; McLachlan A; Gow P; Kumar S; Ly J; Wiltshire C; Robinson E; Dalbeth N
    N Z Med J; 2008 Nov; 121(1285):73-81. PubMed ID: 19079439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations, predictions and decisions--assessing cardiovascular risk assessment.
    Hense HW
    Int J Epidemiol; 2004 Apr; 33(2):235-9. PubMed ID: 15082618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.